| Subsidiaries |
The subsidiaries of the Company, all of which are
100% owned as at 31 December 2025, either directly or through subsidiaries where indicated, and have been included in these financial
statements in accordance with the details set out in the basis of preparation and basis of consolidation note 1, are as follows:
| Schedule of subsidiaries |
|
|
|
|
|
|
| Name |
|
Registered
Office |
|
Nature of
Business |
|
Notes |
| Biodexa Australia PTY Limited |
|
c/o Prime Accounting & Business Advisory, HWT Towel Level 17, 40 City Road, Southbank, VIC, 3006, Australia |
|
Trading company |
|
|
| Biodexa Limited |
|
1 Caspian Point, Caspian Way, Cardiff,
CF10 4DQ |
|
Trading company |
|
|
| Biodexa Ireland Limited |
|
First Floor, Riverside Two, 43-49 Sir John Rogerson's Quay, Dublin 2, Ireland, C02 KV60 |
|
Trading company |
|
|
| Biodexa Pharmaceuticals (Wales) Limited |
|
1 Caspian Point, Caspian Way, Cardiff,
CF10 4DQ |
|
Trading company |
|
|
| Biodexa US, Inc |
|
16601 Blanco Rd, Suite 120, San Antonio, Texas, 78232 |
|
Trading company |
|
|
| Haaland UK Limited |
|
1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ |
|
Dormant |
|
|
| PharMida AG |
|
c/o Kellerhals, Hirschgässlein 11, 4051 Basel, Switzerland |
|
Dormant |
|
(a) (b) |
Notes:
| (a) | Wholly owned subsidiary of Biodexa Limited. |
| (b) | PharMida AG became dormant in January 2016. Proceedings to wind
up the company commenced in 2025. |
|